Published: 2022-07-27

Study of the renal profile in relation to CD4 count in human immuno-deficiency virus patients from a tertiary centre of Bihar

Jyoti Prakash, Bhagwan Das, Chiranjeevi Beernandi, Munish Kumar


Background: Human immuno-deficiency virus (HIV)-positive individuals are at increased risk for kidney disease, including HIV-associated nephropathy (HIVAN). HIV peptides rather than infection may be more important in pathogenesis of HIVAN. Much has been learnt about the pathogenesis and treatment of HIV-associated renal diseases because of the development of animal models and the molecular evaluation of clinical samples.

Methods: We studied 90 consecutive patients with HIV and allocated them into 3 groups, each containing 30 patients on the basis of their CD4 counts. Then each group was divided into two subgroups, X and Y on the basis of whether they received anti-retroviral treatment (HAART) or not. Subgroup X received HAART and subgroup Y did not received HAART.

Results: There was male preponderance (M: F=5.4: 1). Microalbuminuria, increased serum creatinine and decreased GFR was highest among HIV patients having CD4 count below 200 as compared to those having CD4 count of 200-350 and above 350.

Conclusions: Our study demonstrates that both proteinuria and HIVAN are common in HIV infected patients. Proteinuria and glomerular filtration rate have a negative correlation with the CD4 count.


Human immuno-deficiency virus, Nephropathy, Microalbuminuria

Full Text:



UNAIDS. AIDS info, 2017. Available at: Accessed on 19 July 2017.

Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med. 1984;310(11):669-73.

Carbone L, D’Agti V, Cheng JT, Appel GB. Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med. 1989;87:389-95.

Bourgoignie JJ, Meneses R, Ortiz C, Jaffe D, Pardo V. The clinical spectrum of renal disease associated with human immunodeficiency virus. Am J Kidney Dis. 1988;12(2):131-7.

Emem CP, Arogundade F, Sanusi A, Adelusola K, Wokoma F, Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant. 2008;23(2):741-6.

Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest. 1997;100:84-92.

Atta MG, Gallant JE, Rahman MH, Nagajothi N, Racusen LC, Scheel PJ, Fine DM. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant. 2006;21:2809-13.

Ahuja TS, Borucki M, Grady J. HAART improves survival of HIV-infected hemodialysis patients. Am J Kidney DS. 2000;36:574-80.

Han TM, Naicker S, Ramdial PK, Assounga AG. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int. 2006;69(12):2243-50.

Gupta V, Gupta S, Sinha S, Sharma SKA, Dind SK. HIV associated renal disease: A pilot study from north India. Indian J Med Res. 2013;137(5):950-60.

Chander P, Soni A, Suri A, Bhagwat R, Yoo J, Treser G. Renal ultrastructural markers in AIDS-associated nephropathy. Am J Pathol. 1987;126:513-26.

Conaldi PG, Bottelli A, Wade-Evans A, Biancone L, Baj A, Cantaluppi V, et al. HIV-persistent infection and cytokine induction in mesangial cells: a potential mechanism for HIV-associated glomerulosclerosis. AIDS. 2000;14(13):2045-7.

Gardenswartz MH, Lerner CW, Seligson SR, Zabetakis PM, Rotterdam H, Tapper ML, Michelis MF, Bruno MS. Renal disease in patients with AIDS: a clinicopathologic study. Clin Nephrol. 1984(21):197-204.

Katz A, Bargman JM, Miller DC, Guo JW, Ghali VS, Schoeneman MJ. IgA nephritis in HIV-positive patients: a new HIV-associated nephropathy? Clin Nephrol. 2001;25:97-104.

Kirchner JT. Resolution of renal failure after initiation of HAART: 3 cases and a discussion of the literature. AIDS Read. 2002;12:103-5.